Edition:
India

Zimmer Biomet Holdings Inc (ZBH.N)

ZBH.N on New York Stock Exchange

110.17USD
11:08pm IST
Change (% chg)

$0.09 (+0.08%)
Prev Close
$110.08
Open
$110.13
Day's High
$110.73
Day's Low
$109.68
Volume
99,379
Avg. Vol
309,431
52-wk High
$133.45
52-wk Low
$104.28

Select another date:

Tue, Apr 17 2018

BRIEF-Zimmer Biomet Announces FDA Clearance And First Surgical Case Of The Persona Trabecular Metal Tibia

* ZIMMER BIOMET ANNOUNCES FDA CLEARANCE AND FIRST SURGICAL CASE OF THE PERSONA® TRABECULAR METAL™ TIBIA

BRIEF-Zimmer Biomet Says CEO Hanson's FY'17 Total Compensation Was $16.3 Mln

* ZIMMER BIOMET SAYS CEO BRYAN HANSON'S FY 2017 TOTAL COMPENSATION WAS $16.3 MLN - SEC FILING

BRIEF-Zimmer Biomet Holdings Files For Offering Of Floating Rate Notes Due 2021

* ZIMMER BIOMET HOLDINGS INC - FILES FOR OFFERING OF FLOATING RATE NOTES DUE 2021 AND NOTES DUE 2023 - SEC FILING Source text: (http://bit.ly/2tzlxYD) Further company coverage:

BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16

* ZIMMER BIOMET ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 RESULTS

BRIEF-Zimmer Biomet Holdings Announces FDA Clearance Of Sidus Stem-Free Shoulder System

* ZIMMER BIOMET HOLDINGS SAYS THE SIDUS SYSTEM WILL BE AVAILABLE IN U.S BEGINNING IN Q1 OF 2018 Source text for Eikon: Further company coverage:

BRIEF-Zimmer Biomet Says Positive Results From Progress II Trial Of Autologous Protein Solution Prepared With nSTRIDE Aps Kit In Treating Osteoarthritis

* ZIMMER BIOMET HOLDINGS- POSITIVE RESULTS FROM PROGRESS II TRIAL OF AUTOLOGOUS PROTEIN SOLUTION PREPARED WITH NSTRIDE APS KIT IN TREATING OSTEOARTHRITIS Source text for Eikon: Further company coverage:

BRIEF-Zimmer Biomet Names Bryan Hanson CEO

* ZIMMER BIOMET ANNOUNCES APPOINTMENT OF BRYAN C. HANSON AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

BRIEF-Zimmer Biomet Holdings Q3 adjusted earnings per share $1.72

* Q3 earnings per share view $1.74 -- Thomson Reuters I/B/E/S

BRIEF-ZIMMER BIOMET ‍ANNOUNCES U.S. LAUNCH OF VITALITY+, VITAL SPINAL FIXATION SYSTEMS​

* ‍ANNOUNCES U.S. LAUNCH OF VITALITY+ AND VITAL SPINAL FIXATION SYSTEMS​ Source text for Eikon: Further company coverage:

Select another date: